The role of AMPK/mTOR signaling pathway in anticancer activity of metformin.
About the publication
Record:
CHOMANIČOVÁ, Nikola - GAŽOVÁ, Andrea - ADAMIČKOVÁ, Adriana - VALÁŠKOVÁ, Simona - KYSELOVIČ, Ján. The role of AMPK/mTOR signaling pathway in anticancer activity of metformin. In: Physiological Research. 2021. ISSN 0862-8408, Vol. 70, no. 4 (2021), p. 501-508.
(2021: 2.139 - IF, 73 - H-index, 2.369 - IF 5y, 0.528 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q)
(2021: 2.139 - IF, 73 - H-index, 2.369 - IF 5y, 0.528 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q)
Year:
2021
Category:
ADC - Scientific papers in foreign journals
Authors:
CHOMANIČOVÁ Nikola
20 %
GAŽOVÁ Andrea
20 %
ADAMIČKOVÁ Adriana
20 %
VALÁŠKOVÁ Simona
20 %
20 %
UVMP share:
20 %
Edition:
Physiological Research
Vol. 70, no. 4 (2021), p. 501-508
Country of issue:
Czech Republic
ISSN:
0862-8408
Research area:
180 - Medical, pharmaceutical and non-medical health sciences
Scientometrics:
2021: 2.139 - IF, 73 - H-index, 2.369 - IF 5y, 0.528 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q
Language:
english
Citations:
2024-2024: [1] FERREIRA, Marcio Yuri - THOMAZ DE ASSIS, Eloísa Bittencurt - BATISTA, Savio - PALAVANI, Lucca B. - VERLY, Gabriel - CORRÊA, Eduardo Mendes - MITRE, Lucas Pari - SALES DE OLIVEIRA, Jessica - BERTANI, Raphael - MORENO, Daniel Antunes - POLVERINI, Allan Dias. Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis. In World Neurosurgery, 2024-03-01, 183, pp. 239-245.e2. ISSN 18788750. Dostupné na: https://doi.org/10.1016/j.wneu.2024.01.006.
2024-2024: [1] GILLIS, J. D. - PRICE, G. W. - PRASHER, S. O. Perturbations in the earthworm metabolite profile during a two-week exposure to metformin. In Emerging Contaminants, 2024-09-01, 10, 3, pp. ISSN 24056650. Dostupné na: https://doi.org/10.1016/j.emcon.2024.100331.
2024-2024: [1] HUANG, Lucy - WOODS, Charmaine M. - DHARMAWARDANA, Nuwan - MICHAEL, Michael Z. - OOI, Eng Hooi. The mechanisms of action of metformin on head and neck cancer in the pre-clinical setting: a scoping review. In Frontiers in Oncology, 2024-01-01, 14, pp. Dostupné na: https://doi.org/10.3389/fonc.2024.1358854.
2024-2024: [1] NOPORA, Adam - WEIDLE, Ulrich H. CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia. In Cancer Genomics and Proteomics, 2024-01-01, 21, 2, pp. 118-136. ISSN 11096535. Dostupné na: https://doi.org/10.21873/cgp.20434.
2024-2024: [1] SINGH, Priya - SEN, Kaushik - SA, Pratikshya - KHUNTIA, Auromira - RAGHAV, Sunil K. - SWAIN, Rajeeb K. - SAHOO, Sanjeeb Kumar. Piperlongumine based nanomedicine impairs glycolytic metabolism in triple negative breast cancer stem cells through modulation of GAPDH & FBP1. In Phytomedicine, 2024-01-01, 123, pp. ISSN 09447113. Dostupné na: https://doi.org/10.1016/j.phymed.2023.155181.
2024-2024: [1] YAGASAKI, Rina - MORITA, Akane - MORI, Asami - SAKAMOTO, Kenji - NAKAHARA, Tsutomu. The Anti-Diabetic Drug Metformin Suppresses Pathological Retinal Angiogenesis via Blocking the mTORC1 Signaling Pathway in Mice (Metformin Suppresses Pathological Angiogenesis). In Current Eye Research, 2024-01-01, 49, 5, pp. 505-512. ISSN 02713683. Dostupné na: https://doi.org/10.1080/02713683.2024.2302865.
2023-2023: [1] Chang, J.T. - Liang, Y.J. - Leu, J.G. Glucagon-like peptide-1 receptor regulates receptor of advanced glycation end products in high glucose-treated rat mesangial cells. In JOURNAL OF THE CHINESE MEDICAL ASSOCIATION. ISSN 1726-4901, 2023, vol. 86, no. 1, p. 39-46.
2023-2023: [1] IMRAN, M. - SACHDEVA, Geetanjali - MENON, Shyla - DAS, Dhanjit - DAVULURI, Sravanthi - ACHARYA, Kshitish - CHAUDHARI, Uddhav. Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength. In CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2022, vol.101, no. 1, pp. ISSN 0008-4212. Dostupné na: https://doi.org/10.1139/cjpp-2022-0307.
2023-2023: [1] LARSON, E.A. - DALAMAGA, M. - MAGKOS, F. The role of exercise in obesity-related cancers: Current evidence and biological mechanisms. In SEMINARS IN CANCER BIOLOGY. ISSN 1044-579X, 2023, vol. 91, s. 16-26.
2023-2023: [1] MKRTUMYAN, Ashot M. - MARKOVA, Tatiana N. - OVCHINNIKOVA, Margarita A. - IVANOVA, Irina A. - KUZMENKO, Ksenia V. METFORMIN AS AN ACTIVATOR OF AMP-ACTIVATED PROTEIN KINASE. KNOWN AND NEW MECHANISMS OF ACTION. In Diabetes Mellitus, 2023-01-01, 26, 6, pp. 585-595. ISSN 20720351. Dostupné na: https://doi.org/10.14341/DM13044.
2023-2023: [1] PAVLIKOVA, N. Caffeic Acid and Diseases-Mechanisms of Action. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1422-0067, 2023, vol. 24, no. 1, art. no. 588, p. [1-18]
2023-2023: [1] Wu, Z.T. - Wu, L.H. - Zou, L.L. - Wang, M.Q. - Liu, X. Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use. In JOURNAL OF CHEMOTHERAPY. ISSN 1120-009X, 2023, vol. 35, no. 2, p. 131-141.
2023-2023: [1] XU, G.S. - HE, Z.S. - LIU, Y.P. Alisol A 24-acetate ameliorates osteoarthritis progression by inhibiting reactive oxygen species and inflammatory response through the AMPK/mTOR pathway. In IMMUNITY INFLAMMATION AND DISEASE. ISSN 2050-4527, 2023, vol. 11, no. 5, art. no. e848, p. [1-11].
2022-2022: [1] BARRIOS-BERNAL, Pedro - LUCIA ZATARAIN-BARRON, Zyanya - HERNANDEZ-PEDRO, Norma - OROZCO-MORALES, Mario - OLIVERA-RAMIREZ, Alejandra - AVILA-MORENO, Federico - LAURA COLIN-GONZALEZ, Ana - CARDONA, Andres F. - ROSELL, Rafael - ARRIETA, Oscar. Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses. In PHARMACEUTICALS, 2022, vol. 15, no. 7, pp. Dostupné na: https://doi.org/10.3390/ph15070786.
2022-2022: [1] GBELCOVA, Helena - GERGELY, Lajos - SISOVSKY, Vladimir - STRAKA, Lubomir - BOHMER, Daniel - PASTORAKOVA, Andrea - SUSIENKOVA, Katarina - REPISKA, Vanda - KORBEL, Miroslav - DANIHEL, Ludovit - PRISCAKOVA, Petra. PTEN Mutations as Predictive Marker for the High-Grade Endometrial Cancer Development in Slovak Women. In PHYSIOLOGICAL RESEARCH, 2022, vol. 71, no., pp. S125-S135. ISSN 0862-8408. Dostupné na: https://doi.org/10.33549/physiolres.935030.
2022-2022: [1] HUANG, Feng - XIANG, Yuan - LI, Ting - HUANG, You - WANG, Jun - ZHANG, Hui-Min - LI, Han-Han - DAI, Zhou-Tong - LI, Jia-Peng - LI, Hui - ZHOU, Jun - LIAO, Xing-Hua. Metformin and MiR-365 synergistically promote the apoptosis of gastric cancer cells via MiR-365-PTEN-AMPK axis. In PATHOLOGY RESEARCH AND PRACTICE, 2022, vol. 230, no., pp. ISSN 0344-0338. Dostupné na: https://doi.org/10.1016/j.prp.2021.153740.
2022-2022: [1] IMRAN, M. - SACHDEVA, Geetanjali - MENON, Shyla - DAS, Dhanjit - DAVULURI, Sravanthi - ACHARYA, Kshitish - CHAUDHARI, Uddhav. Therapeutic metformin concentrations positively regulate proliferation in endometrial epithelial cells via mTOR activation and augmented mitochondrial strength. In CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2022, vol., no., pp. ISSN 0008-4212. Dostupné na: https://doi.org/10.1139/cjpp-2022-0307.
2022-2022: [1] PENG, Meng-ling - FU, Yu - WU, Chu-wen - ZHANG, Ying - REN, Hang - ZHOU, Shan-shan. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy. In FRONTIERS IN ENDOCRINOLOGY, 2022, vol. 13, no., pp. ISSN 1664-2392. Dostupné na: https://doi.org/10.3389/fendo.2022.907757.
2022-2022: [1] SARSENOVA, Madina - KIM, Yevgeniy - RAZIYEVA, Kamila - KAZYBAY, Bexultan - OGAY, Vyacheslav - SAPAROV, Arman. Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. In FRONTIERS IN IMMUNOLOGY, 2022, vol. 13, no., pp. ISSN 1664-3224. Dostupné na: https://doi.org/10.3389/fimmu.2022.1010399.
2022-2022: [1] SKULI, Sarah J. - ALOMARI, Safwan - GAITSCH, Hallie - BAKAYOKO, A'ishah - SKULI, Nicolas - TYLER, Betty M. Metformin and Cancer, an Ambiguanidous Relationship. In PHARMACEUTICALS, 2022, vol. 15, no. 5, pp. Dostupné na: https://doi.org/10.3390/ph15050626.
2022-2022: [1] TRUJILLO-DEL RIO, C. - TORTAJADA-PEREZ, J. - GOMEZ-ESCRIBANO, A. P. - CASTERA, F. - PEIRO, C. - MILLAN, J. M. - HERRERO, M. J. - VAZQUEZ-MANRIQUE, R. P. Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder. In MECHANISMS OF AGEING AND DEVELOPMENT, 2022, vol. 204, no., pp. ISSN 0047-6374. Dostupné na: https://doi.org/10.1016/j.mad.2022.111670.
2022-2022: [1] YANG, Xiaowei - LAI, Qi - YANG, Xinmin - XIE, Banglin - ZHANG, Bin - ZHANG, Xiaoyong - WEI, Yen. Recent development and advances in the fabrication and biomedical applications of nanoparticle-based drug delivery systems for metformin. In MATERIALS CHEMISTRY FRONTIERS, 2022, vol. 6, no. 2, pp. 128-144. Dostupné na: https://doi.org/10.1039/d1qm01277k.